Trial reportThe International journal of eating disorders2026
Efficacy of the Intervention Against the Stigmatization of Men With Eating Disorders in Primary Healthcare (iSMEsH): Results From a Randomized Waitlist-Controlled Study.
Trial report in The International journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Efficacy of the Intervention Against the Stigmatization of Men With Eating Disorders in Primary Healthcare (iSMEsH): Results From a Randomized Waitlist-Controlled Study.The International journal of eating disorders · 2026Trial
- Eating Disorders in Boys and Men: A Gender-Critical Narrative Review on Recognition, Stigma, and Treatment.The International journal of eating disorders · 2026Review
- Social determinants of mental health in Germany: a systematic scoping review mapping the landscape of researched determinants, outcome measures, and explanatory concepts.International journal for equity in health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveEating disorders (EDs) in men are underdiagnosed and undertreated, partly due to stigma hindering help-seeking. This randomized waitlist-controlled study tested the efficacy of the iSMEsH online anti-stigma intervention targeting German general practitioners (GPs) and medical students. The program aimed to reduce stigmatizing attitudes toward men with EDs and improve knowledge and self-efficacy in managing ED symptoms.
methodA total of 292 participants (130 GPs, 162 medical students) were randomly assigned to immediate intervention or waitlist control. The intervention consisted of six video-based, on-demand modules co-developed with men who have lived experience of an ED, combining education and contact-based strategies. Outcomes included cognitive stigma (knowledge), affective stigma (biased attitudes), and behavioral stigma (treatment self-efficacy), assessed at three timepoints.
resultsThe iSMEsH anti-stigma intervention significantly increased knowledge of male-specific ED presentations and enhanced treatment self-efficacy in both GP and medical student populations. Effects on affective stigma were less consistent. DISCUSSION: Findings support the efficacy of the iSMEsH anti-stigma intervention in improving knowledge and treatment self-efficacy regarding EDs in men among healthcare professionals. Effects on affective stigma were limited and may require longer follow-up periods to be comprehensively captured. The intervention shows promise as a scalable tool to reduce stigma and improve care for men with EDs.
trial registrationOn July 1, 2024 (#181,415; https://aspredicted.org/tzds-h5yq.pdf) and a study protocol is published under Lehe et al. (2025).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.